After a promotional video, Wu Hao, who reappeared in front of everyone, smiled and continued: "In addition to these advanced and cutting-edge medical technologies, we are also actively pursuing research in the medical field, and have already made significant progress in some medical products.
results.
For example, the superphage drug that I introduced at the press conference last year performed very well in this year’s clinical trials.
After thousands of patients with Helicobacter pylori infection in U of T were treated with medication, the cure rate could reach more than 98%. Among them, some patients with repeated Helicobacter pylori infection were completely cured.
Moreover, the super phage in our drug will remain in the human gastrointestinal tract for a period of time and can effectively remove the remaining Helicobacter pylori in the gastrointestinal tract. It can also prevent the invasion of new Helicobacter pylori and lead to reinfection.
From these large numbers of clinical trial treatment cases, we have further verified the efficacy, reliability, and safety of this drug. At present, this drug has passed the preliminary technical evaluation of the pharmaceutical department, and it is expected that this drug will be available next year
Meet with patients.
We also hope that through this drug, we can help more patients suffering from Helicobacter pylori infection get rid of their symptoms and regain their health."
Bang bang bang...
Amid a round of applause, Wu Hao continued: "Through the clinical trials of this drug, we found that this super phage has unique advantages in the treatment of bacterial infections. So we will further develop this super phage."
Conduct research and develop more specific drugs for the treatment of various bacterial infections.
The research on these specific drugs is currently progressing smoothly, and many results have been produced. We will disclose more information in the future based on the research progress of these drugs, so please pay attention in due course."
Speaking of this, Wu Hao paused, looked around the audience, and then said with a smile: "In addition to conducting research on these special drugs, we are also actively exploring how to provide patients with better access to them.
More convenient medical resources.
To give a very simple example, I wonder if you have heard of orphan drugs, as well as some special and life-saving drugs that have harsh storage environments and short shelf lives."
After raising this question, Wu Hao gave everyone at the scene a little reaction time, and then answered: "The so-called orphan drugs are actually drugs that are no longer produced, or are produced in very small quantities, and are not available in primary hospitals.
Due to its use and other problems, this drug is produced in relatively small quantities or is no longer produced. It is specially used to treat some difficult and complicated diseases.
For ordinary patients, these drugs are not needed, so they are dispensable and will not be affected. But for those patients who switch to drugs for difficult and complicated diseases, these drugs are life-saving drugs.
However, because there are few or no pharmaceutical manufacturers producing it, it is very difficult to obtain.
There are often some hot searches for drugs, and patients turn to netizens to find orphan drugs. Some lucky people find these orphan drugs in this way, but some, or many, patients are not so lucky.
In addition, many drugs are not available in small hospitals in small cities and need to be transported from large hospitals in big cities. This invisibly delays a lot of treatment time, leaving many patients without life-saving drugs.
So we are thinking about how to change this misfortune so that all patients can obtain these precious and rare life-saving drugs in a timely manner."
"A friend suggested a good solution to me, which is to buy or build a pharmaceutical factory and then specialize in producing these drugs. Isn't this a solution?
After I heard this suggestion, I shook my head and rejected it. Why, because it cannot cure everyone, and that is not what charity does. A pharmaceutical company cannot solve these problems. What I want is to completely solve this problem.
.
So at my strong request, we subsequently launched a secret research project, which is the technology I will introduce today, 3D printing drug technology."
Hearing Wu Hao's words, the guests and audience members in the audience were surprised and began to discuss. The technology of 3D printing drugs is not new. It was proposed decades ago, and there are many kinds of drugs like this.
Few companies have developed it, and they don't see any difference compared with other traditional medicines. It's just a new concept.
So everyone is a little confused about Wu Hao's proposal of this technology now. Is it because he wants to make a fuss and play with the concept?
Wu Hao on the stage smiled softly, and then said slowly: "After the launch of this project, our technical research team quickly set their sights on the technology of 3D printing drugs, because in their view
Only this technology can meet these requirements and beautiful visions I have put forward.
After comparing related 3D printing drug technologies at home and abroad, and on this basis, combined with our technical advantages in this area, they developed a brand new 3D printing drug technology.
This time, we not only developed a 3D drug printer that can print drugs, but also developed a 3D drug printing system."
After hearing what Wu Hao said, everyone in the audience couldn't help but look at Wu Hao, eager to know what the drug 3D printing system Wu Hao was talking about was.
Facing the attention of everyone in the audience, Wu Hao on the stage smiled and said: "The so-called drug 3D printing system is a comprehensive drug 3D printing system that integrates multiple subsystems. It includes a raw material storage and supply system, a drug
It is composed of ingredient synthesis system, drug 3D printer, drug packaging system, intelligent control management system and other subsystems.
To put it simply, we have simplified and integrated all the complex drug manufacturing and production links in the past, forming a complete production chain from raw materials to finished products.
We call it a pharmaceutical 3D printing system, or a pharmaceutical 3D printer.
We only need to load the raw materials for making drugs into this drug 3D printer like the ink cartridge paper of a printer, and then you can import the drug ingredient data you want to print as needed to print out the drugs you want.
We adopt a modular design for the entire drug 3D printing system. The overall area is very small, only the size of a small container, and the entire system can be installed in an ordinary room.
Therefore, it can be placed in hospitals and even clinics at all levels, so that doctors can print out the drugs they want according to the patient's condition.
In this way, with the help of this equipment, we can print out most of the medicine bottles in very remote areas with poor conditions. As long as we have sufficient pharmaceutical raw materials and accurate
